Table 4.
The comparison of the Treg cells level between patients with SR and with non-SR.
Before the treatment (%) | During the follow-up phase (%) | ||
---|---|---|---|
The rapamycin group | |||
SR | 17 | 5.17 ± 1.50 | 6.94 ± 1.40※ |
Non-SR | 8 | 5.5 ± 1.65 | 6.01 ± 1.22 |
| |||
The cyclosporine A group | |||
SR | 11 | 5.84 ± 1.82 | 6.07 ± 1.14 |
Non-SR | 17 | 5.49 ± 1.39 | 5.11 ± 1.01 |
※ P < 0.005, comparing the Treg cells level before the treatment to that during the follow-up phase in the rapamycin group.